Drug level assessed as recombinant human CYP3A5 mediated compound formation from 3FDT at 10 uM preincubated for 5 mins followed by addition of NADPH m...

Basic Information

ID: ALA3782985

Type: ADME

Description: Drug level assessed as recombinant human CYP3A5 mediated compound formation from 3FDT at 10 uM preincubated for 5 mins followed by addition of NADPH measured after 120 mins by HPLC-TIC chromatography

Format: BAO_0000357

Organism: Homo sapiens

Target: Cytochrome P450 3A5(ALA3019)

Document: ALA3779870

Drug level assessed as recombinant human CYP3A5 mediated compound formation from 3FDT at 10 uM preincubated for 5 mins followed by addition of NADPH measured after 120 mins by HPLC-TIC chromatography: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA3782985

Drug metabolism

Total(2)